SecBot SecBot
8-K ·Filed Nov 13, 2026

APMD

Apnimed, Inc.
BEARISH
Impact 6/10
Horizonweeks Processed3d 7h ago SEC0001193125-26-460864
8-K Item 4.02: Non-reliance on financial statements (restatement)
Actionable Insight ▼ Bearish

The restatement is a classification-only error with no change to total net income or cash, but the admission of a material weakness and the need to restate undermines confidence in financial reporting. Watch for shareholder lawsuits, SEC inquiries, and any further control remediation details in the 10-Q/A.

DirectionBearish
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Apnimed filed an 8-K stating its financial statements for Q2 2026 (three and six months ended June 30, 2026) should no longer be relied upon due to misclassifying an $85.4 million gain on the sale of its SASS joint venture as continuing operations income instead of discontinued operations. The error does not affect total net income, cash, assets, liabilities, or cash flows, but it restates classification and per-share amounts. The company plans to file an amended 10-Q/A on the same day.

Key Facts

  • Audit committee concluded on Nov 13, 2026 that previously issued Q2 2026 financials should no longer be relied upon.
  • Error: $85.4 million gain on sale of SASS equity method investment was classified in continuing operations instead of discontinued operations (ASC 205-20).
  • Affected periods: three and six months ended June 30, 2026.
  • Total net income, cash, assets, liabilities, equity, and cash flows are unchanged.
  • Company had previously disclosed a material weakness in internal controls over financial reporting in the affected 10-Q.
  • Company hired 5 employees to strengthen accounting function and internal controls since the affected report.
  • Company plans to file an amended 10-Q/A on Nov 13, 2026.
  • Auditor is Deloitte & Touche LLP; no auditor change mentioned.

Financial Impact

$85.4 million gain reclassified from continuing to discontinued operations; no impact on total net income, cash, assets, liabilities, equity, or cash flows.

other incomenet income from continuing operationsnet income from discontinued operationsbasic and diluted EPS

Risk Factors

  • Shareholder lawsuits and regulatory investigations are likely given the non-reliance notice.
  • Material weakness in internal controls may persist despite remediation efforts
  • Potential for additional periods or adjustments to be identified
  • Stock price pressure from loss of investor confidence in financial reporting quality

Market Snapshot

Exchange
Nasdaq
Analyst Consensus
90% bullish (10 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-460864
Document: 0001193125-26-460864-index-headers.html0001193125-26-460864
Document: 0001193125-26-460864-index.html0001193125-26-460864
Document: 0001193125-26-460864.txt0001193125-26-460864

Track record

11 reports on APMD

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +18.84% at T+20 after the Jul 31, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $16.28 Now $16.28 +0.00% settles Dec 16
  2. Nov 16, 2026today Press Release Neutral 5/10 Entry price pending
  3. Nov 13, 20263d ago 10-Q/A Neutral 4/10 Entry $17.41 Now $16.28 −6.49% settles Dec 15
  4. Nov 13, 20263d ago 8-K Bearish 6/10 Viewing Entry $17.41 Now $16.28 +6.49% settles Dec 15
  5. Nov 4, 202612d ago SC 13G Neutral 4/10 Entry $15.30 Now $16.28 +6.41% settles Dec 3
  6. Aug 5, 202614w ago Insider Cluster Bullish 7/10 Entry $27.88 to $27.81 Now $16.28 −41.61% ▼ −0.25% −0.85% vs SPY
  7. Aug 3, 202615w ago Insider Buy Bullish 7/10 Entry $25.71 to $26.85 Now $16.28 −36.68% ▲ +4.43% +5.67% vs SPY
  8. Jul 31, 202615w ago 424B4 Mixed 6/10 Entry $25.00 to $26.25 Now $16.28 −34.88% ▲ +5.00% +3.76% vs SPY
  9. Jul 31, 202615w ago EFFECT Bullish 7/10 Entry $25.00 to $29.71 Now $16.28 −34.88% ▲ +18.84% +15.85% vs SPY
  10. Jul 30, 202615w ago 3 Neutral 3/10 Entry $25.00 to $29.71 Now $16.28 −34.88% ▲ +18.84% +15.85% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens Wed (9h 41m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026